More on BLCO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+16.7% Growth)
- Ratings (5.0 Score)
- Holders

Upcoming Events

- Earnings (11/4/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Bausch + Lomb Corporation (NY:BLCO)
Delayed: 18.04 -0.1 (0.55%)
Prev. Close $18.14  
Open$17.92 
52 Wk High$ 
52 Wk Low$ 
Day High$18.17 
Day Low$17.86 
P/E N/A  
EPS$ 
Volume421,308 

Friends, Peers and Foes (?): BHC, DRRX, COO, DOCS, GKOS (more...)

Sep 2, 2026 07:01 AM Bausch + Lomb publishes real-world study on enVista Aspire lenses
Sep 2, 2026 07:00 AM Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience
Sep 1, 2026 06:58 AM Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds
Aug 28, 2026 07:04 AM H.C. Wainwright Reiterates Buy Rating on Bausch & Lomb Corp. (BLCO)
Aug 25, 2026 07:08 AM Bausch & Lomb Corp. (BLCO) Reiterated at Hold by Stifel on Mixed Ph2 Data for Xiidra+Miebo
Aug 24, 2026 04:30 PM Bausch + Lomb advances two eye drop candidates to new trials
Aug 24, 2026 04:30 PM Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
Aug 14, 2026 05:48 PM Form 4 Bausch & Lomb Corp For: Aug 12 Filed by: Trebbi Barbara
Aug 14, 2026 05:45 PM Form 3 Bausch & Lomb Corp For: Aug 05 Filed by: Trebbi Barbara
Aug 14, 2026 05:35 PM Form 4 Bausch & Lomb Corp For: Aug 12 Filed by: PAUL LAURENCE E
View All Articles

Entities mentioned with BLCO

View All Entities